AmeriFlex Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AmeriFlex Group's BMY Position: Q3 2026 in Review
AmeriFlex Group reduced its Bristol-Myers Squibb (BMY) stake by 2.2% in Q3 2026, selling an estimated $16.6K and leaving 11,651 shares worth $744K. The position accounts for 0.26% of the portfolio, ranked #79.
AmeriFlex Group first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- AmeriFlex Group held 11,651 shares of Bristol-Myers Squibb worth $744K as of Q3 2026.
- AmeriFlex Group sold 262 Bristol-Myers Squibb shares in Q3 2026, an estimated $16.6K.
- Bristol-Myers Squibb made up 0.26% of AmeriFlex Group's portfolio in Q3 2026, its #79 holding.
- AmeriFlex Group first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on AmeriFlex Group's 13F filing for Q3 2026, filed 13 Nov 2026.